SCHEMBL17170486

SCHEMBL17170486

c1ccc(-c2ccc3c(c2)c2cc4c(cc2n3-c2cccc(-c3cc(-c5ccccc5)nc(-c5ccccc5)n3)c2)Oc2ccccc2O4)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.40
▸ KMT2A Q03164 7/20 0.40
▸ MAPT P10636 7/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ HPGD P15428 6/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ GLA P06280 1/20 0.40
▸ NTSR1 P30989 1/20 0.38
▸ MAOB P27338 3/20 0.34
▸ MAOA P21397 2/20 0.34
▸ ADORA2A P29274 3/20 0.33
▸ ADORA1 P30542 3/20 0.33
▸ NPSR1 Q6W5P4 3/20 0.33
▸ TSHR P16473 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17170459 0.92 MYC (0.33) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17170357 0.92 KDM4E (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17170484 0.92 GRM5 (0.32) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22763392 0.89 MEN1 (0.48) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22763789 0.89 MEN1 (0.48) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17170315 0.89 KDM4E (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21046159 0.88 MEN1 (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL14749010 0.86 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22763794 0.86 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19928008 0.86 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same DOOSAN SOLUS CO., LTD. (KR) 2020-08-25 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
WO-2015156580-A2 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 주식회사 두산 2015-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OR10J3, ORC3, L1CAM MEN1 2658/4885KMT2A 1375/4885MAPT 1029/4885
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same OR10J3, L1CAM, ICOSLG MEN1 2572/4885KMT2A 1428/4885MAPT 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback